SCHEMBL8320953

SCHEMBL8320953

COc1ccc(C(=O)Cl)c2c3c(oc12)CCCCC3

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 9/20 0.39
▸ MAPT P10636 3/20 0.39
▸ KDM4E B2RXH2 4/20 0.38
▸ KMT2A Q03164 3/20 0.38
▸ MEN1 O00255 2/20 0.38
▸ HPGD P15428 4/20 0.37
▸ MIF P14174 1/20 0.37
▸ TSHR P16473 4/20 0.37
▸ HSD17B10 Q99714 3/20 0.37
▸ NPSR1 Q6W5P4 1/20 0.35
▸ MAOA P21397 1/20 0.35
▸ MAOB P27338 1/20 0.35
▸ GAA P10253 2/20 0.35
▸ PDE4A P27815 2/20 0.34
▸ PDE4B Q07343 2/20 0.34
▸ PDE4C Q08493 2/20 0.34
▸ PDE4D Q08499 2/20 0.34
▸ LMNA P02545 1/20 0.34
▸ RAB9A P51151 2/20 0.34
▸ SMN1; SMN2 Q16637 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8319163 0.99 ALDH1A1 (0.39) ALDH1A1MAPTKDM4EKMT2AMEN1
SCHEMBL8323847 0.85 TSHR (0.37) ALDH1A1MAPTKDM4EKMT2AMEN1
SCHEMBL8324231 0.85 ALDH1A1 (0.43) ALDH1A1MAPTKDM4EKMT2AMEN1
SCHEMBL8325988 0.82 PDE4D (0.35) ALDH1A1MAPTKDM4EKMT2AMEN1
SCHEMBL8325518 0.82 MAPT (0.38) ALDH1A1MAPTKDM4EHPGDTSHR
SCHEMBL8324502 0.81 PDE4A (0.33) PDE4APDE4BPDE4CPDE4D
SCHEMBL8324499 0.79 CNR2 (0.35) PDE4APDE4BPDE4CPDE4D
SCHEMBL8318940 0.78 PDE4A (0.58) ALDH1A1MAPTKDM4EKMT2AMEN1
SCHEMBL8319816 0.78 PDE4D (0.63) PDE4APDE4BPDE4CPDE4D
SCHEMBL8324668 0.77 PDE4A (0.59) ALDH1A1MAPTKDM4EKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004069831-A1 TRICYCLIC COMPOUNDS USEFUL FOR THE TREATMENT OF INFLAMMATORY AND ALLERGIC DISORDERS: PROCESS FOR THEIR PREPARATION GLENMARK PHARMACEUTICALS LTD. (US) 2004-08-19 — — WO disclosed
Send feedback